Form 4: Delek US Director Sells Shares Under 10b5-1 Plan

Delek US Holdings Director Shlomo Zohar sold 7,343 shares of common stock at $46 per share under a pre-arranged 10b5-1 plan.

Summary

• Shlomo Zohar, a Director and 10% Owner of Delek US Holdings, Inc. (DK), reported a transaction.
• On March 19, 2026, Zohar disposed of 7,343 shares of Delek US Holdings Common Stock.
• The shares were sold at a price of $46 per share.
• This transaction was executed pursuant to a Rule 10b5-1 plan, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following this transaction, Shlomo Zohar directly beneficially owns 6,646 shares of Common Stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal due to the insider sale, although the execution under a 10b5-1 plan suggests a pre-planned divestment rather than a reaction to new, adverse information.

Negatives

• An insider, Shlomo Zohar, a Director and 10% Owner, sold 7,343 shares of common stock.
• The sale reduces his direct beneficial ownership to 6,646 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even those pre-arranged under a 10b5-1 plan, are routinely monitored by investors for potential insights into management's perception of future stock performance, though 10b5-1 plans are designed to mitigate such interpretations.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a slightly negative signal, potentially impacting investor sentiment.

Key Dates

Recommendation

While an insider sale by a director and 10% owner could be seen as a negative signal, the transaction was executed under a pre-arranged 10b5-1 plan, which often indicates a planned liquidity event rather than a reaction to new company-specific negative news. Therefore, it warrants a 'hold' rather than a 'sell' unless other fundamental factors suggest otherwise.

Keywords

Delek US Holdings, DK, Insider Sale, Form 4, Shlomo Zohar, 10b5-1 Plan, Director, Stock Transaction